You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
29 September 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) announced on Tuesday that it has agreed to invest USD2bn in newly issued equity in biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) t...
29 September 2026 - Lakewood-Amedex Biotherapeutics Inc (NASDAQ:LABT), a clinical-stage biotechnology company focused on advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin cl...
29 September 2026 - BRC Therapeutics (BRC), a clinical-stage pharmaceutical company developing multimodal cannabinoid therapeutics for neurological and inflammatory conditions, announced on Monday its participation in the Regulatory Perspectives on H...
29 September 2026 - Chinese biotechnology company Ascletis Pharma Inc (HKEX:1672) on Monday reported positive results from a randomised, double-blind, placebo-controlled 28-day proof-of-concept clinical trial with ASC50 in mild-to-moderate plaque pso...
29 September 2026 - Fuse Oncology Inc, a healthcare technology company focused on radiation oncology, announced on Monday that it has formed a strategic collaboration with Associated Medical Professionals of NY (AMP), an affiliate of U.S. Urology Par...
28 September 2026 - Netherlands-based holding company QIAGEN N.V. (NYSE:QGEN) (Frankfurt Prime Standard:QIA) announced on Monday that it has received US Food and Drug Administration (FDA) clearance for a new QIAstat-Dx panel, giving US laboratories a...
28 September 2026 - Radiotherapy technology company Leo Cancer Care on Sunday announced plans to further invest in the treatment experience for children undergoing radiation therapy.Following the world's first paediatric treatments using an upri...